Pharmatech company leveraging quantum-inspired physics and AI for drug discovery.

Tool: Aqemia
Description: Pharmatech company leveraging quantum-inspired physics and AI for drug discovery.
Summary: Aqemia is a pharmatech company that aims to revolutionize the drug discovery process by combining quantum-inspired physics with machine learning. Their unique approach allows for the generation of proprietary data from the earliest stages of drug discovery, significantly speeding up the process and improving the accuracy of identifying innovative drug candidates. This method enables Aqemia to scale drug discovery projects efficiently, akin to tech projects.
Category: Drug Discovery
Tags: Drug Discovery, Predictive Analytics
Use Cases: Aqemia uses its platform to identify potential drug candidates at a pace significantly faster than traditional methods.; The company collaborates with large pharmaceutical companies to accelerate their drug discovery projects.
Platform: Web
Vendor: Aqemia
Target Users: Enterprise
Pricing: not for sale
Regulatory: not a medical device
Meta: Aqemia combines quantum-inspired physics and AI to transform the drug discovery process, enabling faster and more accurate identification of drug candidates.
Content: [LATEST NEWS\\ \\ AQEMIA Hits $100 Million Funding Milestone, Paving Way to Clinical Trials and Global Expansion Starting with London\\ \\ **•**\\ \\ AQEMIA Hits $100 Million Funding Milestone, Paving Way to Clinical Trials and Global Expansion Starting with London\\ \\ **•**\\ \\ READ MORE](https://www.businesswire.com/news/home/20241210380168/en/AQEMIA-Hits-100-Million-Funding-Milestone-Paving-Way-to-Clinical-Trials-and-Global-Expansion-Starting-with-London-UK#:~:text=In%20addition%20to%20reaching%20the,dynamic%20tech%20and%20biotech%20sectors) _INFINITE_ DRUG DISCOVERIES [1\\ \\ Our mission](https://www.aqemia.com/#w-tabs-0-data-w-pane-0) [2\\ \\ Our science](https://www.aqemia.com/#w-tabs-0-data-w-pane-1) [3\\ \\ What we are up to](https://www.aqemia.com/#w-tabs-0-data-w-pane-2) **OUR MISSION** # _SCALE_ DRUG DISCOVERY WITH QUANTUM-INSPIRED _PHYSICS AND AI_ Aqemia is a next-generation pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to scale the drug discovery process, by leveraging a unique-in-the world technology combining quantum-inspired physics and machine learning. **OUR SCIENCE** # UNIQUE PHYSICS GUIDING AI TOWARDS THE RIGHT MOLECULES Unlike usual AI-based platforms that need experimental data to train on, Aqemia tackles drug discovery projects from their earliest stage by generating its own data with unique quantum physics algorithms from 12 years of research at Oxford, Cambridge and ENS/CNRS. The unprecedented pace - 10 000x faster - and accuracy of our physics algorithms enable us to guide efficiently our generative AI to discover innovative drug candidates more rapidly, and scale drug discovery projects as tech projects. **WHAT WE ARE UP TO** # BUILDING THE MOST _SCALABLE_ BIOTECH GENERATOR Aqemia started in 2019 as a deeptech spin-off from École normale supérieure, with a unique, multi-awarded physics theory in the rough. In only 3 years, the company has grown to an amazing team of 50+ people, built and extended repeatedly collaborations with large pharmaceutical companies, and started its own drug discovery pipeline with multiple projects ranging from hit generation to _vivo_ assays. Aqemia's goal is to massively accelerate research projects to be able to scale to dozens of wholly or partly owned drug candidates, placed into a constellation of biotech spin-offs to carry out the clinical trials. # Latest News [December 10, 2024\\ \\ AQEMIA announces two major milestones: reaching $100 million in cumulative funding and launching its global expansion, starting with London, United Kingdom. \\ \\ READ MORE](https://www.businesswire.com/news/home/20241210380168/en/AQEMIA-Hits-100-Million-Funding-Milestone-Paving-Way-to-Clinical-Trials-and-Global-Expansion-Starting-with-London-UK#:~:text=In%20addition%20to%20reaching%20the,dynamic%20tech%20and%20biotech%20sectors) [January 30, 2024\\ \\ Aqemia raises another $30m, pushing its series A to $60m, to accelerate on its proprietary thera

Aqemia combines quantum-inspired physics and AI to transform the drug discovery process, enabling faster and more accurate identification of drug candidates.

Aqemia

Aqemia is a pharmatech company that aims to revolutionize the drug discovery process by combining quantum-inspired physics with machine learning. Their unique approach allows for the generation of proprietary data from the earliest stages of drug discovery, significantly speeding up the process and improving the accuracy of identifying innovative drug candidates. This method enables Aqemia to scale drug discovery projects efficiently, akin to tech projects.

Aqemia

Categories

Description

Summary

Use Cases

Platforms

Regulatory Status

API Available

Added to Directory

Target Customer

Contact